pemetrexed ever pharma 25 mg/ml koncentrat za otopinu za infuziju
ever valinject gmbh, oberburgau 3, unterach am attersee, austrija - pemetrekseddinatrij hemipentahidrat - koncentrat za otopinu za infuziju - 25 mg/ml - urbroj: jedan ml koncentrata sadrži 25 mg pemetrekseda (u obliku pemetrekseddinatrija)
pemetreksed pliva 500 mg/1 bočica prašak za koncentrat za otopinu za infuziju
pliva d.o.o.sarajevo - pemetreksed - prašak za koncentrat za otopinu za infuziju - 500 mg/1 bočica - 1 bočica sa praškom za koncentrat za otopinu za infuziju sadrži: 500 mg pemetrekseda (u obliku pemetrekseddinatrija)
pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastična sredstva - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
copalia hct
novartis europharm limited - amlodipin, валсартан, hidroklorotiazid - hipertenzija - antagonisti angiotenzina ii u kombinaciji, agenti koji djeluju na ренин-ангиотензиновую sustav, antagonisti angiotenzina ii i antagonisti kalcija - liječenje esencijalne hipertenzije kao zamjena terapija u odraslih bolesnika čiji krvni tlak odgovarajuće kontroliran na kombinaciji amlodipin, valsartan i hidroklorotiazid (hct), uzeti kao tri pojedinačnih formulacije ili je dvojan-komponenta i pojedinačnih formulacija.
lorazepam hf 2.5 mg/1 tableta tableta
hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - lorazepam - tableta - 2.5 mg/1 tableta - 1 tableta sadrži: 2,5 mg lorazepama
ontilyv
bial portela & companhia s.a. - opicapone - parkinsonova bolest - antiparkinsonski lijekovi - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.